Advertisement
Home Tags Immunotherapy

Tag: Immunotherapy

Egg-allergic children who undergo egg oral immunotherapy and achieve sustained unresponsiveness eat more egg and have fewer symptoms five years later

AAAAI: Egg Oral Immunotherapy Shows Sustained Benefit in Children

All children with sustained unresponsiveness ingested concentrated and baked egg
Medical science has made tremendous advances in personalized medicine. However

Many Americans Unaware of Promise of Personalized Medicine

41 percent are not at all familiar with personalized medicine; only 5 percent say they are very familiar
For heavily pretreated patients with relapsed/refractory non-Hodgkin lymphoma or Hodgkin lymphoma

ASH: High Response to Tx After Checkpoint Blockade in NHL, HL

Immunotherapy boosts later therapy for relapsed, refractory non-Hodgkin, Hodgkin lymphoma
Adverse events for immune checkpoint inhibitors used to treat non-small cell lung cancer may be more common in real-world settings than reported in the clinical trials that led to U.S. Food and Drug Administration approvals

Immunotherapy Side Effects May Be More Common Than Thought

Higher rates of adverse events observed for immune checkpoint inhibitors in real-world settings
Patients with peanut allergy who received oral immunotherapy

ACAAI: Oral Immunotherapy Is Protective in Peanut Allergy

More patients receiving AR101 able to ingest ≥600 mg peanut protein without dose-limiting symptoms
For patients with metastatic triple-negative breast cancer

Chemoimmunotherapy Ups Survival in Triple-Negative Breast Cancer

Atezolizumab plus nab-paclitaxel prolongs progression-free survival in metastatic disease
A single checkpoint inhibitor can be used to successfully treat two simultaneous types of primary cancer in a patient with Lynch syndrome

Single Agent Treats Two Cancers With Same Genetic Cause

Pembrolizumab treated colon cancer, intrahepatic cholangiocarcinoma in patient with Lynch syndrome
Checkpoint blockade immunotherapy is associated with significant increases in overall survival in a real-world population of patients undergoing treatment for melanoma brain metastases

Novel Immunotherapy May Up Survival in Melanoma Brain Mets

Findings in patients receiving checkpoint blockade immunotherapy for melanoma brain metastases
A new immunotherapy appears to be well tolerated and possibly of benefit in patients with amyotrophic lateral sclerosis

Immunotherapy Promising for Slowing Progression of ALS

Positive results seen for autologous infusions of expanded regulatory T lymphocytes in three patients
A highly personalized therapy targeting multiple tumor antigens shows promise for metastatic breast cancer

Personalized Therapy Promising in Metastatic Breast Cancer

Adaptive transfer of mutant-protein-specific tumor-infiltrating lymphocytes leads to disease regression